Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, highlights the FDA’s recent clearance of BrainsWay’s accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) protocol for Major Depressive Disorder (MDD), including patients with comorbid anxiety. Because Serenity already uses BrainsWay machines in its clinics, patients can now benefit immediately from this faster, convenient, and non-invasive treatment option.
“Serenity is the largest provider of Deep TMS in the country and is one of the only practices certified to conduct its own TMS training,” said Tricia Pease, COO and co-founder of Serenity Mental Health Centers. “These distinctions allow Serenity technicians to receive the highest level of instruction, therefore consistently delivering a high quality of care.”
The accelerated protocol reduces the acute phase from four weeks to just six treatment days, with each session lasting less than 20 minutes. Clinical trials show that it delivers results comparable to the standard Deep TMS protocol, maintaining high rates of symptom improvement, response and remission.
“Unlike clinics that must acquire new BrainsWay equipment, Serenity patients can take advantage of the accelerated protocol right now,” said Pease. “This milestone will help improve nationwide accessibility for those struggling with depression and anxiety.”
TMS treatment at Serenity has an 84% response rate and a 78% remission rate, with results lasting over three years for most patients. The FDA’s recent clearance of the accelerated Deep TMS protocol underscores the growing recognition of this therapy’s effectiveness.
For more information, please visit, www.serenitymentalhealthcenters.com.
